Home › Funds › Arena Capital Advisors, LLC- CA › LIMNW
Arena Capital Advisors, LLC- CA position in LIMNW
LIMINATUS PHARMA INC. · Materials
Arena Capital Advisors, LLC- CA reported holding 29,166 shares of LIMNW (LIMINATUS PHARMA INC.) in its Q3 2026 13F filing — a position valued at US$2K, representing 0.00% of its reported portfolio and ranking #16 among its reported holdings. Arena Capital Advisors, LLC- CA has disclosed LIMNW holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Arena Capital Advisors, LLC- CA's LIMNW position evolved
Arena Capital Advisors, LLC- CA first disclosed a stake in LIMNW in Q2 2025 at 29,166 shares (US$7K). Across 6 filings, Arena Capital Advisors, LLC- CA held the position steady without any share-count change. The most recent filing (Q3 2026) shows 29,166 shares valued at US$2K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 29.17K | $7.00K | New |
| Q3 2025 | 29.17K | $4.32K | Hold |
| Q4 2025 | 29.17K | $1.02K | Hold |
| Q1 2026 | 29.17K | $1.17K | Hold |
| Q2 2026 | 29.17K | $2.19K | Hold |
| Q3 2026 | 29.17K | $1.62K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LIMNW and 13F data
LIMNW (LIMINATUS PHARMA INC.) is a Materials company. 24 other funds we track also report a position in LIMNW — the largest reported positions include DUPONT CAPITAL MANAGEMENT CORP (US$341K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LIMNW
- DUPONT CAPITAL MANAGEMENT CORP 6.25K sh · $341.00K · Q3 2026
More on Arena Capital Advisors, LLC- CA
FAQ
How long has Arena Capital Advisors, LLC- CA held LIMNW?
Arena Capital Advisors, LLC- CA has disclosed LIMNW holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Arena Capital Advisors, LLC- CA's current position in LIMNW?
As of Q3 2026, Arena Capital Advisors, LLC- CA holds 29.17K shares of LIMNW (LIMINATUS PHARMA INC.), valued at $1.62K, representing 0.00% of its reported portfolio and ranking #16.
Has Arena Capital Advisors, LLC- CA been buying or selling LIMNW?
In the latest 13F filing (Q3 2026), Arena Capital Advisors, LLC- CA held unchanged its position in LIMNW.
Which other funds hold LIMNW?
Other major institutional holders of LIMNW include DUPONT CAPITAL MANAGEMENT CORP, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.